Sandler Jonathan, Benson Philip E, Doyle Peter, Majumder Arun, O'Dwyer Jonathan, Speight Paul, Thiruvenkatachari Badri, Tinsley David
Chesterfield Royal Hospital, Chesterfield, United Kingdom.
Am J Orthod Dentofacial Orthop. 2008 Jan;133(1):51-7. doi: 10.1016/j.ajodo.2007.04.032.
The objective of this study was to compare the effectiveness of midpalatal implants with that of headgear as methods of supplementing anchorage during orthodontic treatment. This was a randomized, clinical trial at the Chesterfield and North Derbyshire Royal Hospital NHS Trust and the Charles Clifford Dental Hospital, Sheffield, United Kingdom.
Fifty-one orthodontic patients between the ages of 12 and 39 with absolute anchorage requirements were randomly allocated to receive either a midpalatal implant or headgear to reinforce orthodontic anchorage. The outcome measures of the trial were the surgical and orthodontic success rates of the implants, the number of visits, and the length of treatment time, and the success of treatment as judged by the peer assessment rating (PAR) score reductions and the patients' attitudes to implant placement.
The surgical success rate of the implants was 75%, and the orthodontic success rate was more than 90%. Both implants and headgear proved to be effective methods of reinforcing anchorage. The total number of visits was greater in the implant group, but the overall treatment times were almost identical. There were no statistically significant differences between the 2 groups in PAR scores either at the start or the end of treatment, and the percentages of PAR score reductions were almost identical. The patients had no problems accepting midpalatal implants as a method of reinforcing anchorage.
Midpalatal implants are an acceptable technique for reinforcing anchorage in orthodontic patients and a good alternative for patients who do not wish to wear headgear.
本研究的目的是比较中腭种植体与头帽在正畸治疗中作为补充支抗方法的有效性。这是一项在英国切斯特菲尔德和北德比郡皇家医院国民保健服务信托基金以及谢菲尔德查尔斯·克利福德牙科医院进行的随机临床试验。
51名年龄在12至39岁之间有绝对支抗需求的正畸患者被随机分配接受中腭种植体或头帽以加强正畸支抗。试验的结果指标包括种植体的手术成功率和正畸成功率、就诊次数、治疗时间长度,以及通过同行评估评分(PAR)降低情况和患者对种植体植入的态度来判断的治疗成功率。
种植体的手术成功率为75%,正畸成功率超过90%。种植体和头帽都被证明是加强支抗的有效方法。种植体组的就诊总次数更多,但总体治疗时间几乎相同。两组在治疗开始或结束时的PAR评分没有统计学上的显著差异,PAR评分降低的百分比几乎相同。患者接受中腭种植体作为加强支抗的方法没有问题。
中腭种植体是正畸患者加强支抗的一种可接受技术,对于不希望佩戴头帽的患者是一个很好的替代方法。